Medtronic (MDT) Research Hub

Medtronic (MDT) trades on NYSE, IE in the Healthcare (Medical - Devices) sector. As of 2026-10-26, shares last closed at 94.79 USD (-0.65%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 21.84, market cap 104.77B. This hub links to the full technical, earnings and options research available for MDT.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Medical - Devices)
ExchangeNYSE, IE
Last close94.79 USD (-0.65%)
52-week range77.62 USD – 96.89 USD
Trend regimeRange
14-day RSI66.7 (Bullish)
Trailing P/E21.84
Market cap104.77B
Dividend yield3.48%
Next earnings2026-09-01

Available research for MDT

Earnings

MDT earnings date and last-quarter result: next report 2026-09-01, last quarter beat, P/E 21.84. Updated 2026-07-23.

Options: Covered Call

Covered Call on MDT: how it works, illustrative setup around the real 94.79 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on MDT: how it works, illustrative setup around the real 94.79 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on MDT: how it works, illustrative setup around the real 94.79 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

MDT technical analysis: range, last 94.79 USD, RSI 66.7, 52w range 77.62 USD–96.89 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is MDT in?

Medtronic (MDT) is classified under Healthcare (Medical - Devices), listed on NYSE, IE.

Is MDT in an uptrend or downtrend?

As of 2026-10-26, MDT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is MDT's trailing P/E ratio?

MDT's trailing P/E is 21.84, with a market cap of 104.77B. See the earnings research page for full valuation detail.

When does MDT next report earnings?

MDT is next scheduled to report earnings on 2026-09-01.